The path to improved safety of gene-based products
Drug Discovery World
MAY 11, 2023
In addition, their cumbersome developmental process limits their use for fast-tracked new modalities, such as DNA-based vaccines. Novel gene-based drugs can be severely impacted when HCPs are not distinguished and quantified individually. LC-MS can prove valuable not only in quality control, but also in early development phases.
130 
Let's personalize your content